974-P: Network Meta-analysis of Once Weekly Glucagon-Like Peptide-1 Receptor Agonists: A Focus on Cardiovascular Safety and Mortality

OSAMAH ALFAYEZ; OMAR A. ALMOHAMMED; OMAR ALKHEZI; MAJED S. AL YAMI

doi:10.2337/db20-974-p

974-P: Network Meta-analysis of Once Weekly Glucagon-Like Peptide-1 Receptor Agonists: A Focus on Cardiovascular Safety and Mortality

Diabetes ◽

10.2337/db20-974-p ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 974-P

Author(s):

OSAMAH ALFAYEZ ◽

OMAR A. ALMOHAMMED ◽

OMAR ALKHEZI ◽

MAJED S. AL YAMI

Keyword(s):

Meta Analysis ◽

Cardiovascular Safety ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Cardiovascular safety and glycemic control of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus: A pairwise and network meta-analysis

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2012.09.004 ◽

2012 ◽

Vol 98 (3) ◽

pp. 386-395 ◽

Cited By ~ 22

Author(s):

Feng Sun ◽

Kai Yu ◽

Shanshan Wu ◽

Yuan Zhang ◽

Zhirong Yang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycemic Control ◽

Meta Analysis ◽

Cardiovascular Safety ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Indirect comparison of glucagon like peptide-1 receptor agonists regarding cardiovascular safety and mortality in patients with type 2 diabetes mellitus: network meta-analysis

Cardiovascular Diabetology ◽

10.1186/s12933-020-01070-z ◽

2020 ◽

Vol 19 (1) ◽

Cited By ~ 3

Author(s):

Osamah M. Alfayez ◽

Omar A. Almohammed ◽

Omar S. Alkhezi ◽

Abdulaali R. Almutairi ◽

Majed S. Al Yami

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Indirect Comparison ◽

Cardiovascular Safety ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Faculty Opinions recommendation of Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732267672.793559020 ◽

2019 ◽

Author(s):

Mona Momeni

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Effect of glucagon‐like peptide‐1 receptor agonists in subjects with type 2 diabetes mellitus: a meta‐Analysis

International Journal of Clinical Practice ◽

10.1111/ijcp.14400 ◽

2021 ◽

Author(s):

Weiyun Qian ◽

Fei Liu ◽

Qichao Yang

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Medication adherence to injectable glucagon‐like peptide‐1 (GLP‐1) receptor agonists dosed once weekly vs once daily in patients with type 2 diabetes: A meta‐analysis

International Journal of Clinical Practice ◽

10.1111/ijcp.14060 ◽

2021 ◽

Author(s):

Erin R. Weeda ◽

Alyssa K. Muraoka ◽

Matthew D. Brock ◽

Jessica M. Cannon

Keyword(s):

Type 2 Diabetes ◽

Medication Adherence ◽

Meta Analysis ◽

Once Daily ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Impact of glucagon‐like peptide‐1 receptor agonists on adiponectin concentrations: a meta‐analysis of randomized controlled trials

British Journal of Clinical Pharmacology ◽

10.1111/bcp.14855 ◽

2021 ◽

Author(s):

Luis E. Simental‐Mendía ◽

Adriana Sánchez‐García ◽

Enrique Linden‐Torres ◽

Mario Simental‐Mendía

Keyword(s):

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials

Diabetes Obesity and Metabolism ◽

10.1111/dom.12175 ◽

2013 ◽

Vol 16 (1) ◽

pp. 38-47 ◽

Cited By ~ 108

Author(s):

M. Monami ◽

I. Dicembrini ◽

C. Nardini ◽

I. Fiordelli ◽

E. Mannucci

Keyword(s):

Clinical Trials ◽

Cardiovascular Risk ◽

Randomized Clinical Trials ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Glucagon-like peptide 1 receptor agonists and protection against stroke: a systematic review and meta-analysis

Atherosclerosis ◽

10.1016/j.atherosclerosis.2018.06.170 ◽

2018 ◽

Vol 275 ◽

pp. e62

Author(s):

H. Milionis ◽

F. Barkas ◽

M. Elisaf

Keyword(s):

Systematic Review ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials

Diabetes & Metabolism Journal ◽

10.4093/dmj.2018.0070 ◽

2019 ◽

Vol 43 (4) ◽

pp. 410 ◽

Cited By ~ 5

Author(s):

Yu Mi Kang ◽

Yun Kyung Cho ◽

Jiwoo Lee ◽

Seung Eun Lee ◽

Woo Je Lee ◽

...

Keyword(s):

Meta Analysis ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Long Acting ◽

Cardiovascular Benefit

Download Full-text

Meta-Analysis of the Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Patients With Polycystic Ovary Syndrome

American Journal of Therapeutics ◽

10.1097/mjt.0000000000001418 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Lei Li ◽

Shu-Fang Wang ◽

Meng-Ru Du ◽

Sheng Jiang

Keyword(s):

Polycystic Ovary Syndrome ◽

Polycystic Ovary ◽

Meta Analysis ◽

Efficacy And Safety ◽

Ovary Syndrome ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text